In summary, the exploration of SIRT7 as a therapeutic target in pancreatic cancer elucidates its multifaceted role in tumorigenesis and positions it as a pivotal player in developing innovative treatment strategies. Here, SIRT7 is linked to familial pancreatic carcinoma.